Early Warning Press Release in Accordance with National Instrument 62-103 Ready to Announce with Confidence?
Vancouver, British Columbia--(Newsfile Corp. - January 21, 2026) - Cathay Visions Enterprises Ltd. (the "Acquiror") acquired 102,500 common shares (each a "Common Share") of Optimi Health Corp. (the "Issuer") at a price of $0.32 in the public market.
Prior to giving effect to the foregoing acquisition of Common Shares, the Acquiror owned and/or had control over an aggregate of 12,583,938 Common Shares, representing approximately 13.02% of the issued and outstanding Common Shares of the Issuer on an undiluted basis. Following completion of the acquisition of the Common Shares, the Acquiror owns or has control or direction over, directly or indirectly, 12.686.438 Common Shares, 533,333 warrants, and 350,000 stock options, representing approximately 13.13% of the issued and outstanding Common Shares of the Issuer on an undiluted basis and approximately 13.91% of the total issued and outstanding Common Shares of the Issuer on a partially diluted basis.
The Acquiror may acquire additional securities or dispose of securities of the Issuer in the future either on the open market, privately or otherwise depending on market conditions, reformulation of plans, other available investment business opportunities and/or other relevant factors.
For further information or to receive a copy of the early warning report filed by the Acquiror with securities regulatory authorities in Canada in connection with this press release, please contact Leah Hodges at (604) 377-0403 or refer to the Issuer's SEDAR+ profile at www.sedarplus.ca.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/281095
Source: Cathay Visions Enterprises Ltd.
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Cathay Visions Enterprises Ltd. or all companies in the Banking / Financial Services industry.
Early Warning Press Release in Accordance with National Instrument 62-103
2026-01-21 5:00 PM EST
Early Warning Press Release in Accordance with National Instrument 62-103
2025-07-25 7:00 AM EDT
Apr 30, 2025
Many public companies struggle to maintain investor visibility and engagement between earnings announcements or major financial events....
Biotechnology
Pharmaceutical
Health and Beauty Product
Banking / Financial Services